Results
Bliss GVS Pharma Reports 14% Revenue Growth, Declares Dividend
Bliss GVS Pharma reported consolidated revenue of ₹9,271 crore with 14% growth and net profit rising 53% to ₹1,347 crore for FY26.
The company prepaid all long-term borrowings, reducing debt by 96% to
